Alliance Pharma raises forecast

Pre-tax profits at speciality pharmaceutical company Alliance Pharma are expected to be ahead of current forecasts, it said yesterday in a trading update. Turnover is forecast to come in at £44.9m for 2012, a slight drop on the previous year, while a record increase of £1.1m in sales of Hydromol – the brand name for a range of emollient products – represented 29 per cent of growth over the previous year.